Issue 6/2009
Content (31 Articles)
Inherited susceptibility to non-alcoholic fatty liver disease
R. J. F. Loos, D. B. Savage
The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality
S. E. Kahn, S. Zraika, K. M. Utzschneider, R. L. Hull
Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2)
A. Ramachandran, C. Snehalatha, S. Mary, S. Selvam, C. K. S. Kumar, A. C. Seeli, A. S. Shetty
The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2
C. Chiellini, F. Rubino, M. Castagneto, G. Nanni, G. Mingrone
Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study
W. L. Xu, E. von Strauss, C. X. Qiu, B. Winblad, L. Fratiglioni
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis
C. C. Lee, A. I. Adler, M. S. Sandhu, S. J. Sharp, N. G. Forouhi, S. Erqou, R. Luben, S. Bingham, K. T. Khaw, N. J. Wareham
Bivariate genetic modelling of the response to an oral glucose tolerance challenge: A gene × environment interaction approach
G. F. Liu, H. Riese, T. D. Spector, M. Mangino, S. D. O’Dell, R. P. Stolk, H. Snieder
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
A. Kotronen, L. E. Johansson, L. M. Johansson, C. Roos, J. Westerbacka, A. Hamsten, R. Bergholm, P. Arkkila, J. Arola, T. Kiviluoto, R. M. Fisher, E. Ehrenborg, M. Orho-Melander, M. Ridderstråle, L. Groop, H. Yki-Järvinen
Agreement among type 2 diabetes linkage studies but a poor correlation with results from genome-wide association studies
S. Lillioja, A. Wilton
A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion
S. A. Schäfer, K. Müssig, H. Staiger, F. Machicao, N. Stefan, B. Gallwitz, H. U. Häring, A. Fritsche
Autophagy in human type 2 diabetes pancreatic beta cells
M. Masini, M. Bugliani, R. Lupi, S. del Guerra, U. Boggi, F. Filipponi, L. Marselli, P. Masiello, P. Marchetti
Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes
M. J. MacDonald, M. J. Longacre, E.-C. Langberg, A. Tibell, M. A. Kendrick, T. Fukao, C.-G. Ostenson
Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-κB) signalling in human islets and in a mouse beta cell line
S. A. Sarkar, B. Kutlu, K. Velmurugan, S. Kizaka-Kondoh, C. E. Lee, R. Wong, A. Valentine, H. W. Davidson, J. C. Hutton, S. Pugazhenthi
Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress
R. L. Hull, S. Zraika, J. Udayasankar, K. Aston-Mourney, S. L. Subramanian, S. E. Kahn
Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the KATP channel and insulin secretion in rats
T.-J. Chang, W.-P. Chen, C. Yang, P.-H. Lu, Y.-C. Liang, M.-J. Su, S.-C. Lee, L.-M. Chuang
Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass
V. Delghingaro-Augusto, C. J. Nolan, D. Gupta, T. L. Jetton, M. G. Latour, M. Peshavaria, S. R. Murthy Madiraju, É. Joly, M.-L. Peyot, M. Prentki, J. Leahy
Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance
P. Nivoit, C. Morens, F. A. Van Assche, E. Jansen, L. Poston, C. Remacle, B. Reusens
The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes
S. J. Richardson, A. Willcox, A. J. Bone, A. K. Foulis, N. G. Morgan
The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes
M. Poggi, J. Jager, O. Paulmyer-Lacroix, F. Peiretti, T. Gremeaux, M. Verdier, M. Grino, A. Stepanian, S. Msika, R. Burcelin, D. de Prost, J. F. Tanti, M. C. Alessi
Early autonomic dysfunction in type 1 diabetes: a reversible disorder?
M. Rosengård-Bärlund, L. Bernardi, J. Fagerudd, M. Mäntysaari, C. G. Af Björkesten, H. Lindholm, C. Forsblom, J. Wadén, P.-H. Groop
Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes
M. L. Marcovecchio, R. N. Dalton, C. P. Schwarze, A. T. Prevost, H. A. W. Neil, C. L. Acerini, T. Barrett, J. D. Cooper, J. Edge, J. Shield, B. Widmer, J. A. Todd, D. B. Dunger
Accelerated atrophy of lower leg and foot muscles—a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI)
C. S. Andreassen, J. Jakobsen, S. Ringgaard, N. Ejskjaer, H. Andersen
Blocking AMPA receptor signalling by caroverine infusion does not affect counter-regulation of hypoglycaemia in healthy men
J. Klement, I. Pais, M. Hallschmid, C. Hubold, A. Knispel, K. M. Oltmanns, B. Schultes, J. Born, A. Peters
Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFκB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance
M. P. Sajan, M. L. Standaert, J. Rivas, A. Miura, Y. Kanoh, J. Soto, C. M. Taniguchi, C. R. Kahn, R. V. Farese
IRS2 variants and syndromes of severe insulin resistance
W. E. Bottomley, M. A. Soos, C. Adams, T. Guran, T. A. Howlett, A. Mackie, J. Miell, J. P. Monson, R. Temple, Y. Tenenbaum-Rakover, J. Tymms, D. B. Savage, R. K. Semple, S. O’Rahilly, I. Barroso
Thiamine in diabetic nephropathy: a novel treatment modality?
A. Alkhalaf, N. Kleefstra, K. H. Groenier, S. J. L. Bakker, G. J. Navis, H. J. G. Bilo
Thiamine in diabetic nephropathy: a novel treatment modality? Reply to Alkhalaf A, Kleefstra N, Groenier KH et al. [letter]
N. Rabbani, S. S. Alam, S. Riaz, J. R. Larkin, M. W. Akhtar, T. Shafi, P. J. Thornalley
Optimal dosing of renin–angiotensin–aldosterone system blockers for renal protection: a solved issue?
G. D. Laverman, S. J. L. Bakker, G. J. Navis